Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 5 days agoModerna Inc. said Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed higher efficacy in adults age 18 and older compared with its ...
A Trojan horse for government price-setting
Dallas Morning News· 2 days agoIn 2022, two small life-sciences firms — Genevant Sciences and Arbutus Biopharma — sued biotech giant Moderna for allegedly stealing their patented lipid...
Gateway - Quartz
Quartz· 20 hours agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. -...
FOX 23 News Albany· 3 days agoPomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to ...
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit...
The Conversation· 5 days agoEarlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. Combination vaccines have been successfully ...
OpenAI And Color Health Develop AI-Driven Cancer Care Solutions: Report - Microsoft (NASDAQ:MSFT), ...
Benzinga· 1 day agoOpenAI and startup Color Health have developed an AI assistant, named 'copilot', to support...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via AOL· 4 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the...
NewMediaWire via Yahoo Finance· 9 hours ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...